Chunjiao Yang

Nanning, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Combining network pharmacology and experimental validation to study the action and mechanism of brusatol against lung adenocarcinoma.

Combining network pharmacology and experimental validation to study the action and mechanism of brusatol against lung adenocarcinoma.

Journal: Scientific reports

Published: October 08, 2025

Prognostic model of immune -related immune models of ANLN single gene based on TCGA lung adenocarcinoma database.

Prognostic model of immune -related immune models of ANLN single gene based on TCGA lung adenocarcinoma database.

Journal: Discover oncology

Published: September 29, 2025

Downregulation of GNPNAT1 impaired proliferation and correlates with immune infiltration in lung adenocarcinoma.

Downregulation of GNPNAT1 impaired proliferation and correlates with immune infiltration in lung adenocarcinoma.

Journal: Discover oncology

Published: September 29, 2025

Anticancer Potential of [Formula: see text]-Sitosterol: A Comprehensive Exploration of Mechanisms and Therapeutic Prospects.

Anticancer Potential of [Formula: see text]-Sitosterol: A Comprehensive Exploration of Mechanisms and Therapeutic Prospects.

Journal: The American journal of Chinese medicine

Published: June 29, 2025

3,3'-Diindolylmethane blocks the dissemination of gastric cancer cells in the peritoneal cavity through the MFGE8-MAPK/ERK signaling pathway.

3,3'-Diindolylmethane blocks the dissemination of gastric cancer cells in the peritoneal cavity through the MFGE8-MAPK/ERK signaling pathway.

Journal: Cancer cell international

Published: September 15, 2024

Dissecting the roles of prosaposin as an emerging therapeutic target for tumors and its underlying mechanisms.

Dissecting the roles of prosaposin as an emerging therapeutic target for tumors and its underlying mechanisms.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: July 27, 2024

Comprehensive Analysis of GPSM2: From Pan-Cancer Analysis to Experimental Validation.

Comprehensive Analysis of GPSM2: From Pan-Cancer Analysis to Experimental Validation.

Journal: Journal of cellular and molecular medicine

Published: April 26, 2024

Decrease in GPSM2 mediated by the natural product luteolin contributes to colon adenocarcinoma treatment and increases the sensitivity to fluorouracil.

Decrease in GPSM2 mediated by the natural product luteolin contributes to colon adenocarcinoma treatment and increases the sensitivity to fluorouracil.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: February 10, 2024

Comprehensive analysis for the immune related biomarkers of platinum-based chemotherapy in ovarian cancer.

Comprehensive analysis for the immune related biomarkers of platinum-based chemotherapy in ovarian cancer.

Journal: Translational oncology

Published: May 22, 2023

Pan-cancer analysis of PSAP identifies its expression and clinical relevance in gastric cancer.

Pan-cancer analysis of PSAP identifies its expression and clinical relevance in gastric cancer.

Journal: Pathology, research and practice

Published: November 29, 2021

Identification of Novel Drug Candidate for Epithelial Ovarian Cancer via In Silico Investigation and In Vitro Validation.

Identification of Novel Drug Candidate for Epithelial Ovarian Cancer via In Silico Investigation and In Vitro Validation.

Journal: Frontiers in oncology

Published: July 22, 2021

Pan-Cancer Analysis of NOS3 Identifies Its Expression and Clinical Relevance in Gastric Cancer.

Pan-Cancer Analysis of NOS3 Identifies Its Expression and Clinical Relevance in Gastric Cancer.

Journal: Frontiers in oncology

Published: December 10, 2020

Showing 1-12 of 15

Last Updated: 09/26/2026